Floatz logo

Interferon Gamma-1B

Allogeneic Stem Cell Transplantation

Sawa Ito, MDprotein_peptideEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Allogeneic Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
Bisantrene
Sheba Medical Center
Phase 2B
Ruxolitinib
Massachusetts General Hospital
Phase 2CCC
Cartemis-1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 1/2CCC
Siremadlin
Novartis Pharmaceuticals
Phase 1/2CC

Same molecule, other indications

Interferon Gamma-1B is also rated in:

cancer of unknown primary siteDormant
BB
Indicative ·
64 / 100
View asset →
pulmonary fibrosisDormant
BB
Indicative ·
64 / 100
View asset →
osteopetrosisDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →